Showing 191-200 of 1560 results for "".
Management of Recurrent Squamous Cell Carcinoma of the Head & Neck
https://reachmd.com/programs/global-oncology-academy/management-recurrent-squamous-cell-carcinoma-head-neck/9521/FAQs with Key Opinion Leader: Athanassios Argiris, MD, PhD, FACPExploring Circulating CD34+ Cells as a Biomarker of Fracture Risk in DMD
https://reachmd.com/programs/neurofrontiers/exploring-circulating-cd34-cells-as-a-biomarker-of-fracture-risk-in-dmd/36380/Axatilimab for Chronic Graft-Versus-Host Disease: A Look at a Phase 3 Trial
https://reachmd.com/programs/project-oncology/axatilimab-for-chronic-graft-versus-host-disease-a-look-at-a-phase-3-trial/36312/Chronic graft-versus-host disease (cGVHD) is a serious condition that causes highly debilitating symptoms in patients who’ve received allogeneic hematopoietic stem cell transplantation. That’s why, as of June 2025, a phase 3 trial is currently examining the efficacy and safety of axatilimab comparedTopical Cell-Free Therapy for Psoriasis: A Sponge-Based Secretome Formulation
https://reachmd.com/programs/clinicians-roundtable/topical-cell-free-therapy-for-psoriasis-a-sponge-based-secretome-formulation/36363/Novel Therapies in Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
https://reachmd.com/programs/cme/novel-therapies-in-extensive-stage-small-cell-lung-cancer-es-sclc/36146/Reimagine lung cancer care—discover how new and emerging therapies are reshaping the treatment of SCLC and NSCLCUpdates in Limited-Stage Small Cell Lung Cancer (LS-SCLC)
https://reachmd.com/programs/cme/updates-in-limited-stage-small-cell-lung-cancer-ls-sclc/36145/Reimagine lung cancer care—discover how new and emerging therapies are reshaping the treatment of SCLC and NSCLCAdvancing Care in Non-Clear Cell RCC: Optimizing ICI and TKIs
https://reachmd.com/programs/cme/advancing-care-in-non-clear-cell-rcc-optimizing-ici-and-tkis/29872/Stay at the forefront of nccRCC care by exploring the latest advances in treatment strategies. Gain key insights into optimizing patient selection, enhancing diagnostic accuracy, and managing adverse events to improve patient outcomes. This comprehensive activity delves into emerging data, the ratioNKX019: A Potential New Frontier in Generalized Myasthenia Gravis Therapy
https://reachmd.com/programs/neurofrontiers/nkx019-a-potential-new-frontier-in-generalized-myasthenia-gravis-therapy/30066/Read about NKX019, a new CAR cell therapy that will soon enter clinical trials as a potential treatment for generalized myasthenia gravis.Breathing Beyond Birth: The Symptoms and Treatment of Bronchopulmonary Dysplasia
https://reachmd.com/programs/clinicians-roundtable/breathing-beyond-birth-the-symptoms-and-treatment-of-bronchopulmonary-dysplasia/16081/Tune in to hear an in-depth conversation on the symptoms, impacts, and treatment of premature newborns with bronchopulmonary dysplasia.Rise in Early-Onset Colon Cancer Being Studied Through Single-Cell Sequencing
https://reachmd.com/programs/medical-industry-feature/rise-in-early-onset-colon-cancer-being-studied-through-single-cell-sequencing/29922/What’s behind the rise in colon cancer in younger patients? Listen to a breakdown of key trends, possible causes, and ongoing research to find answers.